Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study

被引:14
作者
de Lusignan, S. [1 ]
Belsey, J. [1 ]
Hague, N. [1 ]
Dhoul, N. [1 ]
Van Vlymen, J. [1 ]
机构
[1] St Georges Univ London, Div Commun Hlth Sci, London SW17 0RE, England
关键词
cardiovascular diseases; cholesterol; computerized statins; family practices; HMG-CoA; medical records system; myocardial ischemia;
D O I
10.1093/pubmed/fdl052
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Statins are recommended for the secondary prevention of cardiovascular disease, although they are often used in suboptimal doses and some patients may not receive lipid-lowering therapy. The Primary Care Data Quality (PCDQ) programme is an audit-based educational intervention. Objective To report the PCDQ programme's effect on the cholesterol management in cardiovascular disease. Subjects and methods Anonymized general practice data from 99 practices; 5% (n = 29 915) had cardiovascular diagnoses. Results Mean cholesterol fell from 4.75 to 4.64 mmol l(-1); patients achieving cholesterol target (< 5 mmol l(-1)) rose from 45.3 to 53.2%. Coronary heart disease patients achieved better control (mean 4.57 mmol l(-1)) than those with stroke (4.87 mmol l(-1)) or peripheral vascular disease (4.93 mmol l(-1)). Statin prescribing increased from 57.5 to 62.7%. Patients with diabetes [odds ratio (OR) 2.06, 95% confidence interval (95% CI) 1.91-2.21], prior myocardial infarction (MI) (OR 1.93, 95% CI 1.80-2.07), revascularization (OR 1.52, 95% CI 1.33-1.73) and smokers (OR 1.31, 95% CI 1.23-1.39) were more likely to receive statins, whereas people aged 75+ (OR 0.48, 95% CI 0.45-0.50), females (OR 0.90, 95% CI 0.86-0.94) and non-CHD-diagnosed (OR 0.36, 95% CI 0.34-0.38) were less likely. Conclusions Diagnostic coding and number of patients who had their cholesterol measured and treated increased. There was no significant change in dosage used or inequity between the different groups prescribed statins.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 41 条
[1]   Statins and stroke prevention [J].
Amarenco, P ;
Lavallée, P ;
Touboul, PJ .
CEREBROVASCULAR DISEASES, 2004, 17 :81-88
[2]   Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates [J].
Baessler, A ;
Fischer, M ;
Huf, V ;
Mell, S ;
Hengstenberg, C ;
Mayer, B ;
Holmer, S ;
Riegger, G ;
Schunkert, H .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 101 (02) :293-298
[3]  
Bazalo G R, 2001, Manag Care, V10, P48
[4]   How do HMG-CoA reductase inhibitors prevent stroke? [J].
Bedi A. ;
Flaker G.C. .
American Journal of Cardiovascular Drugs, 2002, 2 (1) :7-14
[5]   Healthcare data warehousing and quality assurance [J].
Berndt, DJ ;
Fisher, JW ;
Hevner, AR ;
Studnicki, J .
COMPUTER, 2001, 34 (12) :56-+
[6]   Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials [J].
Briel, M ;
Studer, M ;
Glass, TR ;
Bucher, HC .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08) :596-606
[7]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[8]   An educational intervention to improve data recording in the management of ischaemic heart disease in primary care [J].
de Lusignan, S ;
Hague, N ;
Brown, A ;
Majeed, A .
JOURNAL OF PUBLIC HEALTH, 2004, 26 (01) :34-37
[9]  
DELUISGNAN S, 2005, ACTA INFORMATICA MED, V13, P59
[10]  
DELUSIGNAN S, 2003, BR J CARDIOL, V10, P223